Enhancing strategies for COVID-19 solutions in diagnosis, vaccine development and therapies

With the advancement in biomedical research, physicians and scientists have been using technologies to understand the mechanism of action of SARS-CoV-2. Through the understanding on the interaction of the Receptor Binding Domain (RBD) in the spike protein located on the viral coat, with the angiotensin converting enzyme-2 (ACE2) receptor on human cells, we have successfully developed vaccines and monoclonal antibody therapies that can more specifically target SARS-CoV2. In addition, the advancement in scientific technologies to trace the spread and the development of various mutant strains allow us to quickly respond and provide solutions for accurate diagnosis, vaccines and therapies development. As such, a good understanding and connection to the technologies available to develop the vaccines, therapies and diagnosis kits are crucial in navigating out of the pandemic.

In this webinar, you will learn

The available platforms or systems for us to study the mechanism of action of COVID-19 and the immune responses it triggers

How to discover and produce potential COVID-19 antibody treatment in a high throughput manner

The development of diagnostic tools for COVID-19

In this webinar, you will learn

Webinar Details

  • Date: 19th Aug 2021
  • Time: 2PM SGT
  • Speaker:
Dr. How Wing Leung Dr. How Wing Leung

Field Application Scientist, GenScript

How Wing Leung, is the Field Application Scientist, supporting the protein expression and antibody production services at GenScript. Dr. Leung graduated from the National University of Singapore in 2011, majoring in Pharmacology and Neuroscience She has more than 10 years of research experience in molecular biology techniques and extensive knowledge in protein structure modelling, protein expression and its purification

Related Products and Services

Speaker-related Webinars


Do you like the current new website?